UCLA discovers first stroke rehabilitation drug to repair brain damage (2025) (stemcell.ucla.edu)

Article summary

UCLA researchers have discovered a drug called DDL-920 that can repair brain damage caused by stroke in mice, by promoting the recovery of lost brain connections. The study found that physical rehabilitation after stroke improves brain function by repairing connections between neurons, and that DDL-920 can mimic this effect. The drug targets parvalbumin neurons, which help generate brain rhythms that link neurons together. Further studies are needed to understand the safety and efficacy of DDL-920 in humans.

Main themes

• Stroke rehabilitation
• Brain damage repair
• Neurogenesis
• Drug discovery
• Neuroplasticity
• Rehabilitation medicine

What commenters say

• Some commenters are skeptical about the potential of supplements to support neurogenesis, citing the need for a comprehensive approach to health and wellness.
• Others suggest that certain substances, such as lions mane and bacopa monnieri, may have a positive effect on cognitive function and neuroprotection.
• There is disagreement about the relationship between neurogenesis and intelligence, with some arguing that more neuron growth does not necessarily translate to higher intelligence.
• Some commenters emphasize the importance of lifestyle factors, such as sleep, exercise, and diet, in supporting brain health and cognitive function.
• The use of animal models in scientific research is a topic of debate, with some expressing concerns about the ethics of testing on animals.
• There is interest in the potential of psychedelic compounds, such as psilocybin, to support neurogenesis and improve cognitive function, although more research is needed to fully understand their effects.
• Some commenters note that the headline of the article may be misleading, and that the study's findings should be interpreted with caution.
• The discussion touches on the complexity of translating scientific research into practical applications, and the need for further study to fully understand the potential of DDL-920 and other treatments for stroke rehabilitation.